Top

BMC Public Health

Published in:

Open Access 01-12-2023 | Care | Research

Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013–2020

Authors: Hebah Sallom, Abdikarim Abdi, Abdulsalam M Halboup, Bilgen Başgut

Published in: BMC Public Health | Issue 1/2023

Abstract

Introduction

Pharmaceutical care services (PCs) have evolved significantly over the last few decades, with a greater focus on patient’s safety and proven effectiveness in a wide range of contexts. Many of the evidence supporting this technique comes from the United States, the evaluation and adoption of (PCs) which differ greatly across the globe.

Objective

The goal of this study was to identify and assess the efficacy of pharmaceutical care services in various pharmaceutical aspects throughout seventeen Middle Eastern nations.

Method

The Arkesy and O’Malley technique was used to conduct a scoping review. It was conducted using PubMed/Medline, Scopus, Cochrane Library, Springer Link, Clinical Trials, and Web of Science etc. The Van Tulder Scale was utilized in randomized trials research, whereas the dawn and black checklists were used in non-randomized trials research. A descriptive and numerical analysis of selected research was done. The scope of eligible PCs, pharmaceutical implementers, study outcomes, and quality were all identified by a thematic review of research.

Results

There were about 431,753 citations found in this study, and 129 publications were found to be eligible for inclusion after analysing more than 271 full-text papers. The study design was varied, with 43 (33.3%) RCTs and 86 (66.7%) n-RCTs. Thirty-three (25.6%) of the studies were published in 2020. Jordan, Saudi Arabia, and Turkey were home to the majority of the studies (25.6%, 16.3%, and 11.6%) respectively. Thirty-seven studies (19.7%) were concerned with resolving drug related problems (DRPs), whereas 27 (14.4%) were concerned with increasing quality of life (QOL) and 23 (12.2%) with improving drug adherence. Additionally, the research revealed that the average ratings of the activities provided to patients improved every year.

Conclusion

Studies in the Middle East continue to provide evidence supporting the positive impact of pharmaceutical care services on both hard and soft outcomes measured in most studies. Yet there was rare focus on the value of the implemented services. Thus, rigorous evaluation of the economic impact of implemented pharmaceutical care services in the Middle East and assessment of their sustainability is must.

Available only for authorised users

Farris KB, Fernandez-Llimos F, Benrimoj SI. Pharmaceutical care in community pharmacies: practice and research from around the world. Ann Pharmacother. 2005;39(9):1539–41. https://doi.org/10.1345/aph.1G049.CrossRefPubMed

Cooke LH. Re-implementation synthesis. ” Dig Pap - IEEE Comput Soc Int Conf. 1989;462–8. https://doi.org/10.1109/cmpcon.1989.301976.

El Hajj MS, Mekkawi R, Elkaffash R, Saleh R, El A, Awaisi, Wilbur K. Public attitudes towards community pharmacy in Arabic speaking Middle Eastern countries: a systematic review. Res Soc Adm Pharm. 2021;17(8):1373–95. https://doi.org/10.1016/j.sapharm.2020.11.013.CrossRef

Allemann SS, Van Mil JWF, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544–55. https://doi.org/10.1007/s11096-014-9933-x.CrossRefPubMed

Michie S. Implementation science: understanding behaviour change and maintenance. BMC Health Serv Res. 2014;14:6963. https://doi.org/10.1186/1472-6963-14-s2-o9.CrossRef

Mikhael EM, Hassali MA, Hussain SA, Nouri AI, Shawky N. Pharmacist-led interventional programs for diabetic patients in arab countries: a systematic review study. Int J Diabetes Dev Ctries. 2019;39(4):600–10. https://doi.org/10.1007/s13410-019-00720-7.CrossRef

Fox A, Reeves S. Interprofessional collaborative patient-centred care: a critical exploration of two related discourses. J Interprof Care. 2015;29(2):113–8. https://doi.org/10.3109/13561820.2014.954284.CrossRefPubMed

Farha RA, Basheti I, Al Ruz HA, Alsaleh A, AbuRuz S. Assessment of drug-related problems and their impact on blood pressure control in patients with hypertension. Eur J Hosp Pharm. 2016;23(3):126–30. https://doi.org/10.1136/ejhpharm-2015-000712.CrossRefPubMed

Bulatova NR, Aburuz S, Yousef AM. An innovative pharmaceutical care practical course. Adv Heal Sci Educ. 2007;12(2):211–22. https://doi.org/10.1007/s10459-006-0001-8.CrossRef

10.

Aburuz SM, Alrashdan Y, Jarab A, Jaber D, Alawwa IA. Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan. Int J Clin Pharm. 2013;35(5):780–9. https://doi.org/10.1007/s11096-013-9806-8.CrossRefPubMed

11.

N. Z., P. B., and W. K.J., “The impact of antimicrobial stewardship strategies on antibiotic appropriateness and prescribing behaviours in selected countries in the Middle East: a systematic review,” East Mediterr Heal J. 2017;23(6):430–40.

12.

Al-Jumah KA, Qureshi NA. Impact of pharmacist interventions on patients’ adherence to antidepressants and patient-reported outcomes: a systematic review. Patient Prefer Adherence. 2012;6:87–100. https://doi.org/10.2147/PPA.S27436.CrossRefPubMedPubMedCentral

13.

Chisholm-Burns MA, et al. Economic effects of pharmacists on health outcomes in the United States: a systematic review. Am J Heal Pharm. 2010;67:1624–34. https://doi.org/10.2146/ajhp100077.CrossRef

14.

Review AS. Of Cardiovascular Disease Risk factors. 2015;171(16):1441–53.

15.

Elias MN, Burden AM, Cadarette SM. The impact of pharmacist interventions on osteoporosis management: a systematic review. Osteoporos Int. 2011;22(10):2587–96. https://doi.org/10.1007/s00198-011-1661-7.CrossRefPubMedPubMedCentral

16.

Mekonnen AB, McLachlan AJ, Brien JAE. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2). https://doi.org/10.1136/bmjopen-2015-010003.

17.

Davis B, Qian J, Ngorsuraches S, Jeminiwa R, Garza KB. The clinical impact of pharmacist services on mental health collaborative teams: a systematic review. J Am Pharm Assoc. 2020;60(5):S44–S53. https://doi.org/10.1016/j.japh.2020.05.006.CrossRef

18.

Barry HE, Hughes CM. The Pharmacist Guide to Implementing Pharmaceutical Care. Springer International Publishing; 2019.

19.

Peters DH, Adam T, Alonge O, Agyepong IA, Tran N. Republished research: implementation research: what it is and how to do it. Br J Sports Med. 2014;48(8):731–6. https://doi.org/10.1136/bmj.f6753.CrossRefPubMed

20.

Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):1–15. https://doi.org/10.1186/1748-5908-4-50.CrossRef

21.

Moullin JC, Sabater-Hernández D, Benrimoj SI. Model for the evaluation of implementation programs and professional pharmacy services. Res Soc Adm Pharm. 2016;12(3):515–22. https://doi.org/10.1016/j.sapharm.2015.08.003.CrossRef

22.

Blanchard C, Livet M, Ward C, Sorge L, Sorensen TD, McClurg MR. The active implementation frameworks: a roadmap for advancing implementation of Comprehensive Medication Management in primary care. Res Soc Adm Pharm. 2017;13(5):922–9. https://doi.org/10.1016/j.sapharm.2017.05.006.CrossRef

23.

Berenguer B, La Casa C, de la Matta MJ, Martin-Calero MJ. Pharmaceutical Care: past, Present and Future. Curr Pharm Des. 2005;10(31):3931–46. https://doi.org/10.2174/1381612043382521.CrossRef

24.

Dixon-Woods M. Using framework-based synthesis for conducting reviews of qualitative studies. BMC Med. 2011;9:9–10. https://doi.org/10.1186/1741-7015-9-39.CrossRef

25.

Kheir N, Zaidan M, Younes H, El Hajj M, Wilbur K, Jewesson PJ. Pharmacy education and practice in 13 middle eastern countries. Am J Pharm Educ. 2008;72(6). https://doi.org/10.5688/aj7206133.

26.

van Tulder M, Furlan A, Bombardier C, Bouter L. “Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group,” Spine (Phila. Pa 1976). 2003;28(12):1290–1299. https://doi.org/10.1097/01.brs.0000065484.95996.af.

27.

Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377–84. https://doi.org/10.1136/jech.52.6.377.CrossRefPubMedPubMedCentral

28.

Abu-Oliem AS, Al-Sharayri MG, AlJabra RJ, Hakuz NM. A clinical trial to investigate the role of clinical pharmacist in resolving/preventing drug related problems in ICU patients who receive anti-infective therapy. Jordan J Pharm Sci. 2013;6(3):292–8. https://doi.org/10.12816/0001507.CrossRef

29.

Al-Baghdadi H, et al. Introducing clinical pharmacy services to cardiovascular clinics at a university hospital in Northern Cyprus. Int J Clin Pharm. 2017;39:1185–93. https://doi.org/10.1007/s11096-017-0534-3.CrossRefPubMed

30.

Al alawneh M, Nuaimi N, Basheti IA. Pharmacists in humanitarian crisis settings: assessing the impact of pharmacist-delivered home medication management review service to syrian refugees in Jordan. Res Soc Adm Pharm. 2019;15(2):164–72. https://doi.org/10.1016/j.sapharm.2018.04.008.CrossRef

31.

Babushkina EA, Belokopytova LV, Grachev AM, Meko DM, Vaganov EA. Variation of the hydrological regime of Bele-Shira closed basin in Southern Siberia and its reflection in the radial growth of Larix sibirica. Reg Environ Chang. 2017;17(6):1725–37. https://doi.org/10.1007/s10113-017-1137-1.CrossRef

32.

Basheti IA, Rizik M, Bulatova NR. Home medication management review in outpatients with alarming health issues in Jordan: a randomized control trial. J Pharm Heal Serv Res. 2018;9(2):91–100. https://doi.org/10.1111/jphs.12213.CrossRef

33.

Basheti IA, Tadros OKI, Aburuz S. Value of a community-based Medication Management Review service in Jordan: a prospective randomized controlled study. Pharmacotherapy. 2016;36(10):1075–86. https://doi.org/10.1002/phar.1833.CrossRefPubMed

34.

Al-Hashar A, et al. Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use. Int J Clin Pharm. 2018;40(5):1154–64. https://doi.org/10.1007/s11096-018-0650-8.CrossRefPubMed

35.

Faqeer N, Mustafa N, Abd Al-jalil N, Qur’an T. Impact of clinical pharmacists in an inpatient medical oncology service: a prospective study at a comprehensive cancer center in Jordan. J Oncol Pharm Pract. 2021;27(4):897–901. https://doi.org/10.1177/1078155220943277.CrossRefPubMed

36.

Ertuna E, Arun MZ, Ay S, Koçak FÖK, Gökdemir B, İspirli G. Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in turkey: a retrospective study. Clin Interv Aging. 2019;14:587–600. https://doi.org/10.2147/CIA.S201039.CrossRefPubMedPubMedCentral

37.

Weiler DM, Crist JD. Diabetes self-management in a latino social environment. Diabetes Educ. 2009;35(2):285–92. https://doi.org/10.1177/0145721708329545.CrossRefPubMed

38.

Mahwi TO, Obied KA. “Role of the pharmaceutical care in the management of patients with type 2 diabetes mellitus,” Int. J. Pharm. Sci. Res. 2013;4(4):1363–1369. [Online]. Available: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L368928622%5Cn; http://www.ijpsr.com/V4I4/14Vol. 4, Issue 4, IJPSR, April 2013, RA- 2225, Paper 14.pdf%5Cnhttp://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=23205148&id=doi:&atitle=Role.

39.

Wishah RA, Al-Khawaldeh OA, Albsoul AM. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial. Diabetes Metab Syndr Clin Res Rev. 2015;9(4):271–6. https://doi.org/10.1016/j.dsx.2014.09.001.CrossRef

40.

Tourkmani AM, et al. Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study. BMC Fam Pract. 2018;19(1):1–10. https://doi.org/10.1186/s12875-017-0677-2.CrossRefPubMedPubMedCentral

41.

Ebid AHI, Mobarez MA, Ramadan RA, Mahmoud MA. Impact of a clinical pharmacist intervention program on the Follow-up of Type-2 Diabetic Patients. Hosp Pharm. 2020. https://doi.org/10.1177/0018578720973881.CrossRefPubMedPubMedCentral

42.

Alsuwayni B, Alhossan A. Impact of clinical pharmacist-led diabetes management clinic on health outcomes at an academic hospital in Riyadh, Saudi Arabia: a prospective cohort study. Saudi Pharm J. 2020;28(12):1756–9. https://doi.org/10.1016/j.jsps.2020.11.002.CrossRefPubMedPubMedCentral

43.

Al-Taweel DM, Awad AI, Johnson BJ. Pharmacists’ contributions to the delivery of pharmaceutical care to patients with type 2 diabetes in Kuwait. Int J Diabetes Dev Ctries. 2014;34(2):108–15. https://doi.org/10.1007/s13410-013-0169-4.CrossRef

44.

Sarayani A, et al. Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice. Int J Clin Pharm. 2018;40(2):345–53. https://doi.org/10.1007/s11096-018-0593-0.CrossRefPubMed

45.

Noormandi A, Karimzadeh I, Mirjalili M, Khalili H. Clinical and economic impacts of clinical pharmacists’ interventions in Iran: a systematic review. DARU J Pharm Sci. 2019;27(1):361–78. https://doi.org/10.1007/s40199-019-00245-8.CrossRef

46.

Nikvarz N, Seyedi Z. Improved utilisation of venous thromboembolism prophylaxis in renal-impaired patients following a clinical pharmacist intervention. Eur J Hosp Pharm. 2019;1–5. https://doi.org/10.1136/ejhpharm-2019-002030.

47.

Alkoudsi KT, Al-Qudah R, Basheti IA. Assessing the effectiveness of a pharmaceutical care service on the quality of life of women with polycystic ovarian syndrome living in war and non-war countries. J Eval Clin Pract. 2020;26(5):1467–77. https://doi.org/10.1111/jep.13310.CrossRefPubMed

48.

Hadi BA, Sbeitan SM. Clinical pharmacy intervention post tonsillectomy: a randomized control trial. Int J Clin Pharm. 2015;37(1):133–8. https://doi.org/10.1007/s11096-014-0051-6.CrossRefPubMed

49.

Tahaineh LM, Khasawneh AH. A randomised control trial to evaluate the clinical pharmacist’s role in managing iron deficiency anaemia patients. Int J Pharm Pract. 2018;26(1):55–62. https://doi.org/10.1111/ijpp.12358.CrossRefPubMed

50.

Hijazi MA, Shatila H, El-Lakany A, Al Rifai H, Aboul-Ela M, Naja F. Role of community pharmacists in weight management: results of a national study in Lebanon. BMC Health Serv Res. 2020;20(1):1–12. https://doi.org/10.1186/s12913-020-05258-7.CrossRef

51.

Abdelaziz H, et al. Impact of clinical pharmacy services in a short stay unit of a hospital emergency department in Qatar. Int J Clin Pharm. 2016;38(4):776–9. https://doi.org/10.1007/s11096-016-0290-9.CrossRefPubMed

52.

Xie X, Hui T, Luo Y, Li H, Li G, Wang Z. “Research on the Properties of Low Temperature and Anti-UV of Asphalt with Nano-ZnO/Nano-TiO2/Copolymer SBS Composite Modified in High-Altitude Areas,” Adv. Mater. Sci. Eng. 2020;2020. https://doi.org/10.1155/2020/9078731.

53.

Bahnasawy SM, El Wakeel LM, Beblawy NE, El-Hamamsy M. Clinical pharmacist-provided services in Iron-overloaded Beta-thalassaemia Major Children: a New Insight into Patient Care. Basic Clin Pharmacol Toxicol. 2017;120(4):354–9. https://doi.org/10.1111/bcpt.12695.CrossRefPubMed

54.

Qudah B, Albsoul-Younes A, Alawa E, Mehyar N. Role of clinical pharmacist in the management of blood pressure in dialysis patients. Int J Clin Pharm. 2016;38(4):931–40. https://doi.org/10.1007/s11096-016-0317-2.CrossRefPubMed

55.

M. A.A., Y. M.A., and A. A.A., “Pharmaceutical care intervention among Saudi hypertensive patients in hospital outpatients’ clinic at Taif city,” Int. J. Pharm. Sci. Rev. Res. 2017;42(2):58–64. [Online]. Available: http://globalresearchonline.net/journalcontents/v42-2/12.pdf%0Ahttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed18&NEWS=N&AN=614716135.

56.

El Hajj MS, Mahfoud ZR, Al Suwaidi J, Alkhiyami D, Alasmar AR. Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: a cross-sectional study in the state of Qatar. J Eval Clin Pract. 2016;22(3):329–40. https://doi.org/10.1111/jep.12477.CrossRefPubMed

57.

Marouf BH, Yusif IA, Najim RH. Role of pharmacist intervention in the management of Anemia Associated with chronic kidney Diseases at the Hemodialysis setting. J Young Pharm. 2020;12(2):162–8. https://doi.org/10.5530/jyp.2020.12.33.CrossRef

58.

Suleiman A, et al. Pharmacist-perceived barriers to pharmaceutical care of chronic and end-stage kidney disease patients in Saudi Arabia. Arch Pharm Pract. 2016;7(2):54. https://doi.org/10.4103/2045-080x.181037.CrossRef

59.

Almomani BA, Mayyas RK, Ekteish FA, Ayoub AM, Ababneh MA, Alzoubi SA. The effectiveness of clinical pharmacist’s intervention in improving asthma care in children and adolescents: Randomized controlled study in Jordan. Patient Educ Couns. 2017;100(4):728–35. https://doi.org/10.1016/j.pec.2016.11.002.CrossRefPubMed

60.

El Hajj MS, Kheir N, Al Mulla AM, Shami R, Fanous N, Mahfoud ZR. Effectiveness of a pharmacist-delivered smoking cessation program in the state of Qatar: a randomized controlled trial. BMC Public Health. 2017;17(1):1–12. https://doi.org/10.1186/s12889-017-4103-4.CrossRef

61.

Europe PCareN. “Classification for Drug related problems,” Word J. Int. Linguist. Assoc. 2020;9. [Online]. Available: http://www.pcne.org/upload/files/15_PCNE_classification_V4-00.pdf.

62.

Mukhtar M et al. “Effectiveness of clinical Pharmacist Collaborative Care in Resolution of Antibiotic Drug-Related problems in an Intensive Care Unit,” 2020;18(1):1–7. https://doi.org/10.5580/IJID.55560.

63.

Najjar MF, Sulaiman SAS, Jeraisy MA, Balubaid H. The impact of a combined intervention program: an educational and clinical pharmacist’s intervention to improve prescribing pattern in hospitalized geriatric patients at King Abdulaziz Medical City in Riyadh, Saudi Arabia. Ther Clin Risk Manag. 2018;14:557–64. https://doi.org/10.2147/TCRM.S157469.CrossRefPubMedPubMedCentral

64.

Alshammari E. Role of clinical pharmacist in Dose Adjustment of Renally eliminated drugs in Cardiac patients with renal impairment. Int Res J Pharm. 2019;10(2):70–4. https://doi.org/10.7897/2230-8407.100245.CrossRef

65.

Khalili H, Karimzadeh I, Mirzabeigi P, Dashti-Khavidaki S. Evaluation of clinical pharmacist’s interventions in an infectious diseases ward and impact on patient’s direct medication cost. Eur J Intern Med. 2013;24(3):227–33. https://doi.org/10.1016/j.ejim.2012.11.014.CrossRefPubMed

66.

El-Refae HG, Abuhamdah SMA. Impact of clinical pharmacist intervention on therapy-related problems and costs in a cardiovascular unit of a tertiary healthcare facility in Amman, Jordan. Trop J Pharm Res. 2017;16(12):3013–21. https://doi.org/10.4314/tjpr.v16i12.28.CrossRef

67.

Vazin A, et al. Clinical and economical impacts of guideline implementation by the pharmaceutical care unit for high cost medications in a referral teaching hospital. BMC Health Serv Res. 2018;18(1):1–10. https://doi.org/10.1186/s12913-018-3627-3.CrossRef

68.

Tonin FS, Aznar-Lou I, Pontinha VM, Pontarolo R, Fernandez-Llimos F. Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions. Pharm Pract (Granada). 2021;19(1):1–10. https://doi.org/10.18549/PharmPract.2021.1.2302.CrossRef

69.

Almzeiny M, et al. Perception and satisfaction of stakeholders regarding the patient care area pharmacist initiative in a military hospital in Saudi Arabia. Trop J Pharm Res. 2020;19(2):401–9. https://doi.org/10.4314/tjpr.v19i2.24.CrossRef

70.

Mai C, Qiu L, Zeng Y, Tan X. Lactobacillus casei strain Shirota enhances the ability of Geniposide to activate SIRT1 and decrease inflammation and oxidative stress in septic mice. Front Physiol. 2021;12:1–14. https://doi.org/10.3389/fphys.2021.678838.CrossRef

71.

Hammour KA, Farha RA, Basheti I. Hospital pharmacy medication reconciliation practice in Jordan: perceptions and barriers. J Eval Clin Pract. 2016;22(6):932–7. https://doi.org/10.1111/jep.12565.CrossRefPubMed

72.

Sultana K, Al Jeraisy M, Al Ammari M, Patel R, Zaidi STR. Attitude, barriers and facilitators to practice-based research: cross-sectional survey of hospital pharmacists in Saudi Arabia. J Pharm Policy Pract. 2016;9(1):1–8. https://doi.org/10.1186/s40545-016-0052-z.CrossRef

73.

Katoue MG. Enablers and challenges to pharmacy practice change in Kuwait hospitals: a qualitative exploration of pharmacists’ perceptions. J Eval Clin Pract. 2021;27(2):272–9. https://doi.org/10.1111/jep.13450.CrossRefPubMed

74.

Abdulameer SA. Knowledge and pharmaceutical care practice regarding inhaled therapy among registered and unregistered pharmacists: an urgent need for a patient-oriented health care educational program in Iraq. Int J COPD. 2018;13:879–88. https://doi.org/10.2147/COPD.S157403.CrossRef

75.

Falamić S, Hadziabdic MO, Lucijanić M, Marušić S, Vrca VB. “Pharmacist-led interventions might improve quality of life among older adult patients receiving warfarin treatment in rural areas: results from a randomized controlled trial,” 2020;1–2. https://doi.org/10.21203/rs.2.23204/v1.

76.

Masoom Akhtar M, Waheed A, Sheikh D, Hussain A. Role of pharmacist in improving Health Related Quality of Life (HRQoL) in Hypertensive Pateints in Pakistan. Am J Pharmacol Sci. 2014;2:17–22. https://doi.org/10.12691/ajps-2-5b-5.CrossRef

77.

Melchionda F, et al. LETTER TO THE EDITOR a novel WT1 mutation in Familial Wilms Tumor. Pediatr Blood Cancer. 2013:1388–9. https://doi.org/10.1002/pbc.CrossRef

78.

Basheti IA, Ayasrah SM, Basheti MM, Mahfuz J, Chaar B. The syrian refugee crisis in Jordan: a cross sectional pharmacist-led study assessing post-traumatic stress disorder. Pharm Pract (Granada). 2019;17(3):1–10. https://doi.org/10.18549/PharmPract.2019.3.1475.CrossRef

79.

Alawneh MAL, Nuaimi N, Abu-Gharbieh E, Basheti IA. A randomized control trial assessing the effect of a pharmaceutical care service on syrian refugees’ quality of life and anxiety. Pharm Pract (Granada). 2020;18(1):1–9. https://doi.org/10.18549/PharmPract.2020.1.1744.CrossRef

80.

Mossialos E et al. “From ‘retailers’ to health care providers: Transforming the role of community pharmacists in chronic disease management,” Health Policy (New. York). 2015;119(5):628–639. https://doi.org/10.1016/j.healthpol.2015.02.007.

81.

van Eikenhorst L, Taxis K, van Dijk L, de Gier H. “Pharmacist-led self-management interventions to improve diabetes outcomes. A systematic literature review and meta-analysis,” Front. Pharmacol. 2017;8:1–14. https://doi.org/10.3389/fphar.2017.00891.

82.

Pande S, Hiller JE, Nkansah N, Bero L. “The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries,” Cochrane Database Syst. Rev. 2013;2013(2). https://doi.org/10.1002/14651858.CD010398.

83.

Tan ECK, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Soc Adm Pharm. 2014;10(4):608–22. https://doi.org/10.1016/j.sapharm.2013.08.006.CrossRef

84.

Farkouh ME, et al. Risk factor control for coronary artery disease secondary prevention in large randomized trials. J Am Coll Cardiol. 2013;61:1607–15. https://doi.org/10.1016/j.jacc.2013.01.044.CrossRefPubMed

85.

Pham V, Jeffe DB, Noirot LA, Dunagan WC, Reichley RM, Bailey TC. “Physicians’ Knowledge and Attitudes about Coronary Heart Disease Prevention Guidelines and Technology Assisted Interventions.,” AMIA Annu. Symp. Proc. 2005;1079.

86.

et al., “Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital.,” AMIA … Annual Symposium proceedings / AMIA Symposium. AMIA Symposium. 2006;850.

87.

Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen NM, Lapointe. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am Heart J. 2012;163(4):657–65. https://doi.org/10.1016/j.ahj.2012.01.019.CrossRefPubMed

88.

Goldstein M, Israel B, Medical D, Kosty M. Future supply of and demand for oncologists. J Oncol Pract. 2008;4(6):300–2. https://doi.org/10.1200/jop.0863001.CrossRef

89.

Sessions JK, Valgus J, Barbour SY, Iacovelli L. Role of oncology clinical pharmacists in light of the oncology workforce study. J Oncol Pract. 2010;6(5):270–2. https://doi.org/10.1200/JOP.000037.CrossRefPubMedPubMedCentral

90.

Daifi C, Feldpausch B, Roa PA, Yee J. Implementation of a clinical pharmacist in a Hemodialysis Facility: a Quality Improvement Report. Kidney Med. 2021;3(2):241–7. https://doi.org/10.1016/j.xkme.2020.11.015.CrossRefPubMedPubMedCentral

91.

Gong C, Hasson NK, Lurn BL. “Diabetes Disease Management Clinic on the a,” 1999;5(6):511–5.

92.

Kelly C, Rodgers PT. Implementation and evaluation of a pharmacist-managed Diabetes Service. J Manag Care Pharm. 2000;6(6):488–93. https://doi.org/10.18553/jmcp.2000.6.6.488.CrossRef

93.

Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996;30(3):238–43. https://doi.org/10.1177/106002809603000305.CrossRefPubMed

94.

Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998;32(6):636–41. https://doi.org/10.1345/aph.17095.CrossRefPubMed

95.

Jorgenson D, Dalton D, Farrell B, Tsuyuki RT, Dolovich L. Guidelines for pharmacists integrating into primary care teams. Can Pharm J. 2013;146(6):342–52. https://doi.org/10.1177/1715163513504528.CrossRef

96.

Ebert L, Hoffman K, Levett-Jones T, Gilligan C. ‘They have no idea of what we do or what we know’: australian graduates’ perceptions of working in a health care team. Nurse Educ Pract. 2014;14(5):544–50. https://doi.org/10.1016/j.nepr.2014.06.005.CrossRefPubMed

97.

D’Amour D, Goulet L, Labadie JF, Martín-Rodriguez LS, Pineault R. A model and typology of collaboration between professionals in healthcare organizations. BMC Health Serv Res. 2008;8:1–14. https://doi.org/10.1186/1472-6963-8-188.CrossRef

98.

Waltz TJ, et al. Use of concept mapping to characterize relationships among implementation strategies and assess their feasibility and importance: results from the Expert Recommendations for Implementing Change (ERIC) study. Implement Sci. 2015;10(1):1–8. https://doi.org/10.1186/s13012-015-0295-0.CrossRef

99.

Simpson SH, et al. Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with type 2 diabetes: results from a randomized controlled trial. Diabet Med. 2015;32(7):899–906. https://doi.org/10.1111/dme.12692.CrossRefPubMed

100.

Neilson AR, et al. Pharmacist-led management of chronic pain in primary care: costs and benefits in a pilot randomised controlled trial. BMJ Open. 2015;5(4). https://doi.org/10.1136/bmjopen-2014-006874.

101.

Marra C, Johnston K, Santschi V, Tsuyuki RT. Cost-effectiveness of pharmacist care for managing hypertension in Canada. Can Pharm J. 2017;150(3):184–97. https://doi.org/10.1177/1715163517701109.CrossRef

102.

Bojke C, et al. Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. Br J Gen Pract. 2010;60(570):21–7. https://doi.org/10.3399/bjgp09X482312.CrossRef

Title: Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013–2020
Authors: Hebah Sallom
Abdikarim Abdi
Abdulsalam M Halboup
Bilgen Başgut
Publication date: 01-12-2023
Publisher: BioMed Central
Keyword: Care
Published in: BMC Public Health / Issue 1/2023
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-023-16199-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013–2020

Abstract

Introduction

Objective

Method

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Objective

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Complexity and interplay of faced adversities and perceived health and well-being in highly vulnerable pregnant women—the Mothers of Rotterdam program

A systematic review of the impact of the COVID-19 pandemic on the mental health of adolescents and young people with disabilities aged 15–29 years

Use of a multi-method approach to rapidly assess the impact of public health policies at the state and local level: a case study of flavored e-cigarette policies

The impact of climate change on the lives and livelihoods of readymade garment (RMG) workers: an exploratory study in selected readymade garment factories in Bangladesh

Associations between physical activity, screen time, sleep time and selected academic skills in 8/9-year-old children

Study on the prediction model of atherosclerotic cardiovascular disease in the rural Xinjiang population based on survival analysis